Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells
L M Souza(Amgen (United States)), Karl Welte(University Children's Hospital Tübingen), Joan Bruszewski(Amgen (United States)), Kenneth K. Chen(Amgen (United States)), Jean M. Barendt(Amgen (United States)), Janice Gabrilove(Memorial Sloan Kettering Cancer Center), Douglas C. Murdock(Amgen (United States)), Roland Mertelsmann(Unknown), Vicki R. Chazin(Amgen (United States)), E Platzer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Hsieng S. Lu(Amgen (United States)), Malcolm A.S. Moore(Memorial Sloan Kettering Cancer Center), Krisztina M. Zsebo(Unknown), Thomas C. Boone(Amgen (United States)), Por H. Lai(Amgen (United States))
Cited by 1,245
Related Papers
Effects of the <i>obese</i> Gene Product on Body Weight Regulation in <i>ob</i> / <i>ob</i> Mice
|Science|1995|4k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
|Proceedings of the National Academy of Sciences|1985|522
Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology
|Annals of Hematology|2004|488